Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer
Background: Prioritization of breast cancer patients based on the risk of resistance to tamoxifen plays a significant role in personalized therapeutic planning and improving disease course and outcomes. Methods: In this work, we demonstrate that a genome-wide pathway-centric computational framework...
Main Authors: | Sarra M. Rahem, Nusrat J. Epsi, Frederick D. Coffman, Antonina Mitrofanova |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420304230 |
Similar Items
-
NR4A1 Regulates Tamoxifen Resistance by Suppressing ERK Signaling in ER-Positive Breast Cancer
by: Yu Cheon Kim, et al.
Published: (2021-06-01) -
ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
by: Anieta M. Sieuwerts, et al.
Published: (2020-03-01) -
ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
by: Anieta M. Sieuwerts, et al.
Published: (2020-03-01) -
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
by: Liu Y, et al.
Published: (2020-08-01) -
The Use of Tamoxifen in Prevention of Adhesions after FlexorTendons Surgery in Rabbits
by: Seyed Mehdi Moosavizadeh, et al.
Published: (2019-02-01)